Clinical trial
BRIDGE - Blocking Receptor of IL-1β for Donor Graft Edema Reduction
NCT07410312 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- BRIDGE - Blocking Receptor of IL-1β for Donor Graft Edema Reduction
- Lead sponsor
- Northwestern University
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- October 1, 2026
- Completion date
- December 31, 2027
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lung transplant recipient